New advances in the treatment of hyperlipidemias
| dc.contributor.advisor | Pórszász, Róbert | |
| dc.contributor.advisordept | Debreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézet | hu_HU |
| dc.contributor.author | Park, Suyeong | |
| dc.contributor.department | DE--Általános Orvostudományi Kar | hu_HU |
| dc.contributor.opponent | Drimba, László | |
| dc.contributor.opponent | Szentmiklósi, József András | |
| dc.contributor.opponentdept | Kenézy Kórház Központi Aneszteziológiai és Intezív Terápiás Osztály | hu_HU |
| dc.date.accessioned | 2019-09-26T11:13:56Z | |
| dc.date.available | 2019-09-26T11:13:56Z | |
| dc.date.created | 2019-05-12 | |
| dc.description.abstract | This review includes another types of treatments of the hyperlipidemia. The first part of this review is for the classic treatments for hyperlipidemia; statin, and non-statin classic drugs, such as resin, ezetimibe, niacin, and fibrate. The second part is for New advanced approaches in the treatments of the hyperlipidemia, including CETP Inhibitor, MTTP Inhibitor, PCSK9 Inhibitor, Bempedoic acid, Gemcabene, and dual PPAR Modulator. | hu_HU |
| dc.description.course | általános orvos | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 49 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/273777 | |
| dc.language.iso | en | hu_HU |
| dc.subject | Hyperlipidemia | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány | hu_HU |
| dc.title | New advances in the treatment of hyperlipidemias | hu_HU |